(redirected from Cholinesterase inhibitors)
Also found in: Medical.
CHEICholinesterase Inhibitors
CHEIChannel Hot Electron Injection
CHEIChina Health Economics Institute (China Ministry of Health)
CHEICanadian Healthy Eating Index (diet screening tool)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Request for the Report Summary: Cholinesterase inhibitors will remain the topselling drugs for treating lewy body dementia, accounting for nearly 60% share in 2018.
The cholinesterase inhibitors prevent the enzyme acetylcholinesterase from breaking down the neurotransmitter acetylcholine, which plays a role in attention, learning memory and other functions.
* A literature review identified published and unpublished randomized controlled trials in English and Chinese in which cholinesterase inhibitors were compared with placebo or another drug for treating delirium in non-critically ill patients.
Prompted by the aforementioned findings and in the continuation of our ongoing research on thiazoles (24) and pyrazolines (25) as cholinesterase inhibitors, we designed a new series of thiazolylpyrazoline derivatives based on the molecular hybridization of thiazole and pyrazoline scaffolds.
Theoretically, cholinesterase inhibitors can cause some cardiovascular effects, including bradycardia, conductive block, and QT prolongation [6,7], because the heart is rich in cholinesterase.
We have acetylcholine receptors all over our body and cholinesterase inhibitors make more of the chemical available bodywide, increasing the risk of side effects like nausea, loss of appetite, joint pain and muscle cramping.
[4] Cholinesterase inhibitors were also one of the main substance categories resulting in CCU admission; however, they played a more predominant role at CMH, accounting for 55% of all admissions.
Menichini, Natural products and their derivatives as cholinesterase inhibitors in the treatment of neurodegenerative disorders: an update, Curr.
Should you ever need to take a cholinesterase inhibitor, there are FDA-approved options.
Advanced dementia patient = memantine + cholinesterase inhibitor. Medicine becomes a flowchart rather than a thinking specialty.
Moreover, well-known adverse effects of cholinesterase inhibitors and memantine include syncope, hip fracture, arrhythmia, and urinary retention; adverse effects of statins in the elderly include myopathy memory loss, confusion, elevated blood glucose, and diabetes.
Our search for cholinesterase inhibitors from Malaysian medicinal plants indicated that the methanol extract of G.